Abbott is opening up a new pharmaceutical R&D lab in Singapore, its first such facility in Southeast Asia. In a release, the company said that the new lab would be "conducting stability studies, including studies on active pharmaceutical ingredients and novel formulations, to support global regulatory requirements for new pharmaceutical products." Release